Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000891293-12-000045
Filing Date
2012-08-10
Accepted
2012-08-10 18:57:21
Documents
1
Period of Report
2012-08-10

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 3721
  Complete submission text file 0000891293-12-000045.txt   5057
Mailing Address 3101 WESTERN AVENUE SUITE 600 SEATTLE WA 98121
Business Address 3101 WESTERN AVENUE SUITE 600 SEATTLE WA 98121 2062827100
CELL THERAPEUTICS INC (Issuer) CIK: 0000891293 (see all company filings)

EIN.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address
BIANCO JAMES A (Reporting) CIK: 0001198554 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-12465 | Film No.: 121025656